COMMUNIQUÉS West-GlobeNewswire

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
22/05/2024
Late clinical-stage company to provide update on Phase 3 treatment for celiac disease BOCA RATON, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (Nasdaq: ENTO) (“ [...]
Antion Biosciences announces development of safety-enhanced and off-the-shelf CAR T-cells for autoimmune disease
22/05/2024
Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseases GENEVA, May 22, 2024 (GLOBE NEWSWIRE) -- Antion Biosciences (Antion), a Geneva-based cell and gene therapy company developing “off- [...]
G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
22/05/2024
- Jupiter Bioventures will Gain Exclusive Rights for the Clinical Development, Regulatory Submissions, and Commercialization of Lerociclib for Radioprotection in the US, Europe, Japan, and All Other Global Markets [...]
CorVel Announces Revenues and Earnings
22/05/2024
FORT WORTH, Texas, May 22, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2024. Revenues for the quarter were $207 million, an increase [...]
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
22/05/2024
LAKEWOOD, Colo., May 22, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (“Mesa”) (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at [...]
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
22/05/2024
COPENHAGEN, Denmark, May 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 187,020 as a consequence of employees’ exercise of warrants. The [...]
Philips ePatch and AI analytics platform rolled out to 14 hospitals across Spain to monitor heart patients
22/05/2024
May 22, 2024 Philips wearable ePatch and AI analytics platform help detect potentially life-threatening irregular heartbeats The solution helps University Hospital Vall d’Hebron achieve reduced average length of stay, [...]
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
22/05/2024
IMCIVREE expected to be funded and available for use in England and Wales within three months through the National Health Service in specialist centres BOSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, [...]
deepull appoints Didier Deltort to its Board of Directors
22/05/2024
deepull appoints Didier Deltort to its Board of Directors Barcelona, Spain – 22 May 2024 – deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification for sepsis [...]
Arbutus to Present Imdusiran Data at EASL Congress 2024
22/05/2024
WARMINSTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to [...]
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
22/05/2024
PARIS and CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand [...]
NANOBIOTIX fait le point sur ses résultats financiers et opérationnels du premier trimestre 2024
22/05/2024
PARIS et CAMBRIDGE, Mass., 22 mai 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société » ), société française de biotechnologie en phase de développement clinique avancé, pionnière des [...]
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases
22/05/2024
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases Nantes, France - Ingelheim, Germany - 22 May 2024, 7:30am CET - [...]
OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliques
22/05/2024
OSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliques Nantes, France et [...]
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe
22/05/2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Wyost® (denosumab) and Jubbonti® (denosumab) approved by EC for all indications of denosumab reference medicines Xgeva® and Prolia® [...]
Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®
22/05/2024
PRESS RELEASE: REGULATED INFORMATION – INSIDE INFORMATION 22 MAY 2024, 07:00 CEST Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump® Positive and collaborative [...]
Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk
22/05/2024
Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke. 1 The Roche Diagnostics Tina-quant® Lp(a) [...]
Predicine to Present 9 Liquid Biopsy Studies at ASCO 2024
22/05/2024
HAYWARD, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Predicine, Inc. A leading precision oncology company, announced today that it will present data from 9 ctDNA studies at ASCO 2024, spotlighting the clinical utility of [...]
Deenova enters Belgian market with tender win at AZ Saint Lucas Hospital
22/05/2024
MILAN, Italy, May 22, 2024 (GLOBE NEWSWIRE) -- Deenova , the European leader in pharmacy automation, is thrilled to announce its successful tender win at AZ Saint Lucas Hospital in Brugge, facilitated by its business [...]

Pages